Is MEDP or SOLV cheaper?

On trailing earnings, SOLV is cheaper: MEDP trades at a 28.99 P/E and SOLV at 9.37.

Which has grown faster, MEDP or SOLV?

Over the past five years, MEDP grew revenue faster — MEDP at a 22.91% CAGR versus SOLV at 2.72%.

Is MEDP or SOLV more profitable?

SOLV runs the higher net margin — MEDP at 17.19% versus SOLV at 17.33%.

Medpace Holdings, Inc. (MEDP) vs Solventum Corporation (SOLV)

SOLV leads on 8 of 12 compared metrics.

A side-by-side comparison of Medpace Holdings, Inc. and Solventum Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 17, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

MEDP

Medpace Holdings, Inc.

$13.18B

$461.60Healthcare

SOLV

Solventum Corporation

$13.26B

$76.56Healthcare

Total return — MEDP vs SOLV

growth of $100 · last 2y

MEDP +14.6%SOLV -4.3%MEDP compounded faster

MEDP SOLV

MEDP vs SOLV: by the numbers

•SOLV is the larger company ($13.26B vs $13.18B market cap).
•SOLV trades at the lower earnings multiple (9.37 vs 28.99 P/E).
•SOLV converts more revenue to profit (17.33% vs 17.19% net margin).
•MEDP grew revenue faster over the past five years (22.91% vs 2.72% CAGR).

Which is better, MEDP or SOLV?

Metric tally: MEDP 4 · SOLV 8

It depends on what you're optimizing for:

ValueSOLV(lower P/E)

GrowthMEDP(faster 5Y revenue CAGR)

QualityMEDP(higher ROIC)

Metrics side by side

Valuation

Metric	MEDP	SOLV
P/E ratio	28.99	9.37●
Forward P/E	25.12	10.84●
P/S ratio	4.99	1.63●
P/B ratio	22.34	2.70●
PEG ratio	1.82	0.04●
EV / EBITDA	21.40	6.52●
FCF yield	5.52%	—

Profitability

Metric	MEDP	SOLV
Gross margin	29.07%	53.67%●
Operating margin	21.02%	25.54%●
Net margin	17.19%	17.33%
ROE	76.95%●	28.82%
ROIC	67.94%●	17.76%

Growth (annualized)

Metric	MEDP	SOLV
Revenue CAGR (5Y)	22.91%●	2.72%
EPS CAGR (5Y)	30.90%●	6.26%
FCF CAGR (5Y)	25.76%	—
Total return CAGR (5Y)	20.87%	—

Frequently asked

Which is better, MEDP or SOLV?: It depends on your goal. value: SOLV (lower P/E); growth: MEDP (faster 5Y revenue CAGR); quality: MEDP (higher ROIC). Across all compared metrics, SOLV leads 8 to 4.
Is MEDP or SOLV cheaper?: On trailing earnings, SOLV is cheaper: MEDP trades at a 28.99 P/E and SOLV at 9.37.
Which has grown faster, MEDP or SOLV?: Over the past five years, MEDP grew revenue faster — MEDP at a 22.91% CAGR versus SOLV at 2.72%.
Is MEDP or SOLV more profitable?: SOLV runs the higher net margin — MEDP at 17.19% versus SOLV at 17.33%.

Go deeper

Full MEDP analysis Full SOLV analysis Interactive comparison tool

Dig into the metrics

Medpace P/E ratio Solventum P/E ratio Medpace dividend yield Solventum dividend yield Medpace ROE Solventum ROE Medpace operating margin Solventum operating margin Medpace revenue growth Solventum revenue growth Medpace free cash flow Solventum free cash flow

Medpace & Solventum appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 17, 2026.